|
FY2022
12 months to Sep 30, 2022
|
FY2021
11 months to Sep 30, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net Income (loss) | ||
| Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities: | ||
| General and administrative expenses paid by Sponsor under promissory note | ||
| Change in fair value of derivative warrant liabilities | ||
| Offering costs—derivative warrant liabilities | ||
| Financing costs - derivative warrant liabilities | ||
| Income from investments held in Trust Account | ||
| Loss on sale of Private Placement Warrants | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Accounts payable | ||
| Net cash provided by (used in) operating activities | ||
| Cash Flows from Investing Activities: | ||
| Cash deposited in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Repayment of note payable to related party | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds received from private placement | ||
| Offering costs paid | ||
| Reimbursement from underwriters | ||
| Net cash provided by financing activities | ||
| Cash—end of the period | ||
| Net change in cash | ||
| Cash - beginning of the period | ||
| Cash - end of the period | ||
| Supplemental disclosure of noncash financing activities: | ||
| Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Offering costs funded with note payable - related party | ||
| Deferred legal fees | ||
| Deferred underwriting commissions |
Loading...
